Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• MicroRNAs (miRNAs) are crucial regulators of cellular processes and disease, including inflammation.
• Inflammation is a key driver of atherogenesis, a process central to cardiovascular disease.
• Mechanistic insights into miRNA roles in atherosclerosis (AS) are still emerging.

Purpose of the Study:

• To investigate the specific role and mechanism of microRNAs in the development and progression of atherosclerosis.
• To identify key miRNAs involved in the inflammatory pathways implicated in AS.

Main Methods:

• Quantitative real-time polymerase chain reaction (PCR) was used to measure miRNA transcriptase levels.
• Thoracic aorta samples from Apolipoprotein E knockout mice and plasma samples from coronary artery disease (CAD) patients were analyzed.
• In vivo and in vitro experiments were conducted to assess the functional role of miR-155.

Main Results:

• miR-155 levels were significantly elevated in both atherosclerotic mice and patients with coronary artery disease compared to controls.
• miR-155 was identified as part of a negative feedback loop that reduces inflammatory cytokine production, thereby decreasing AS progression.
• miR-155 was shown to modulate the inflammatory response and the mitogen-activated protein kinase (MAPK) pathway by targeting mitogen-activated protein kinase kinase kinase 10.

Conclusions:

• miR-155 demonstrates a preventative role in the development and progression of atherosclerosis.
• miR-155 is implicated in the posttranscriptional regulation of inflammatory responses and the MAPK pathway through its targeting of mitogen-activated protein kinase kinase kinase 10.